Schuch, L.A.* ; Forstner, M.* ; Rapp, C.K.* ; Li, Y.* ; Smith, D.E.C.* ; Mendes, M.I.* ; Delhommel, F. ; Sattler, M. ; Emiralioğlu, N.* ; Taskiran, E.Z.* ; Orhan, D.* ; Kiper, N.* ; Rohlfs, M.* ; Jeske, T.* ; Hastreiter, M.* ; Gerstlauer, M.* ; Torrent-Vernetta, A.* ; Moreno-Galdó, A.* ; Kammer, B.* ; Brasch, F.* ; Reu-Hofer, S.* ; Griese, M.*
FARS1-related disorders caused by bi-allelic mutations in cytosolic phenylalanyl-tRNA synthetase genes: Look beyond the lungs!
Clin. Genet. 99, 789-801 (2021)
Aminoacyl-tRNA synthetases (ARSs) catalyze the first step of protein biosynthesis (canonical function) and have additional (non-canonical) functions outside of translation. Bi-allelic pathogenic variants in genes encoding ARSs are associated with various recessive mitochondrial and multisystem disorders. We describe here a multisystem clinical phenotype based on bi-allelic mutations in the two genes (FARSA, FARSB) encoding distinct subunits for tetrameric cytosolic phenylalanyl-tRNA synthetase (FARS1). Interstitial lung disease with cholesterol pneumonitis on histology emerged as an early characteristic feature and significantly determined disease burden. Additional clinical characteristics of the patients included neurological findings, liver dysfunction, and connective tissue, muscular and vascular abnormalities. Structural modeling of newly identified missense mutations in the alpha subunit of FARS1, FARSA, showed exclusive mapping to the enzyme's conserved catalytic domain. Patient-derived mutant cells displayed compromised aminoacylation activity in two cases, while remaining unaffected in another. Collectively, these findings expand current knowledge about the human ARS disease spectrum and support a loss of canonical and non-canonical function in FARS1-associated recessive disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Fars1 ; Farsa ; Farsb ; Aminoacyl-trna Synthetases ; Children´s Interstitial Lung Disease (child) Lipoid Pneumonia ; Cholesterol Pneumonitis
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
0009-9163
e-ISSN
1399-0004
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 99,
Heft: 6,
Seiten: 789-801
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Wiley
Verlagsort
111 River St, Hoboken 07030-5774, Nj Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-503000-001
Förderungen
German Center for Lung Research
Deutsches Zentrum für Lungenforschung
ERA-Net for Research on Rare Diseases
E-Rare-3
European Cooperation in Science and Technology
European Molecular Biology Organization
Helmholtz-Gemeinschaft
Spanish Society of Pneumology and Thoracic Surgery
Spanish Society of Pediatric Pulmonology
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2021-05-11